AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2015

Dec 18, 2015

34983_dirs_2015-12-18_b74c23ad-69d2-4205-886a-f6683fdda5fa.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-16	Common Shares	A	448896	—	Acquired	4937854	Indirect
2015-12-16	Common Shares	A	624938	—	Acquired	6874314	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-16	Stock Options	$0.1	A	50000	Acquired	2019-12-23	Common Shares (50000)	Direct
2015-12-16	Stock Options	$0.32	A	20000	Acquired	2016-07-11	Common Shares (20000)	Direct
2015-12-16	Stock Options	$0.09	A	22500	Acquired	2018-06-18	Common Shares (22500)	Direct
2015-12-16	Warrants	$0.23	A	17000	Acquired	2017-05-15	Common Shares (17000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	6249376	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.1	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.32	2016-07-11	Common Shares (200000)	750000	Direct
Stock Options	$0.09	2018-06-18	Common Shares (225000)	995000	Direct
Warrants	$0.23	2017-05-15	Common Shares (170000)	170000	Indirect

Footnotes

F1: Adjusted to forward 1.1 split

F2: Adjusted Price to Forward 1.1 Split